Opinion
Understanding filler reversal with hyaluronidase
Hyaluronidase is approved by the Food and Drug Administration for several indications, but its use in cosmetic procedures is off-...
Article
Hidradenitis Suppurativa: The Basics
News
Remnant cholesterol improves CV risk prediction
Adding remnant cholesterol to guideline prediction models should improve identification of those who would benefit most from statin treatment for...
News
Metastatic lobular, ductal cancers respond similarly
Lobular cancers differ physiologically, but trial results generally apply to ductal tumors.
News
Survival for elderly breast cancer patients 25% after 4 years
The finding is based on an analysis of data between 2012 and 2016 from the SEER-Medicare database.
News
‘Large benefit’ in ovarian function suppression for breast cancer
Absolute gain for adding ovarian function suppression to tamoxifen increases with longer follow-up.
News
Neighborhood analysis links breast cancer outcomes to socioeconomic status
“This study should make clinicians cognizant of the potential for biases in management of metastatic breast cancer in terms of socioeconomic...
Article
Hidradenitis Suppurativa: Clinical Presentation
News
FDA approves setmelanotide for obesity in Bardet-Biedl syndrome
The FDA cleared setmelanotide (Imcivree) for people age 6 and older with obesity due to a rare genetic disorder.
News
Meta-analysis points to safety of acetylcholine coronary testing
Experts hope the study will provide assurance and prompt greater adoption of invasive functional angiography to diagnose and treat coronary...